| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.1 |